Company profile: DIAsource Diagnostics
1.1 - Company Overview
Company description
- Provider of clinical diagnostic products and IVD solutions, developing, manufacturing, and marketing RIA and ELISA assays (manual and automated) for endocrinology, autoimmunity, and infectious diseases; monoclonal antibodies for in-vitro diagnostic assays; DIASpot immunodot platform for auto-immune testing; free 25OH Vitamin D assays; and the DIA5000 rapid test reader.
Products and services
- ELISA Assays: Over 200 enzyme-linked immunosorbent assay products for endocrinology and autoimmunity, in‑vitro diagnostic (IVD), with reagents for open ELISA automated analyzers supporting diverse clinical diagnostic applications
- RIA Assays: Radioimmunoassay products for endocrinology, autoimmunity, and infectious diseases, in‑vitro diagnostic (IVD), offering manual and automated configurations for clinical laboratories across these testing areas
- Antibodies: Monoclonal components developed for use in in‑vitro diagnostic assays, covering bone metabolism, cancer, and diabetes applications, supporting assay construction across those disease areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DIAsource Diagnostics
DCS Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic devices as a pharmaceutical firm, specializing in the sale and development of devices for human use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCS Diagnostics company profile →
Bio-AMD
HQ: United Kingdom
Website
- Description: Provider of biotechnology as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-AMD company profile →
Millennium Health
HQ: United States
Website
- Description: Provider of accredited specialty laboratory services delivering drug testing and integrated intelligence, including Millennium UDT urine drug tests with quantitative results, Millennium OFT oral fluid testing, Continuum telemedicine-compatible oral fluid collection kits, the Signals Report analyzing drug test results for trends, RADAR Hotline consultations with toxicologists and clinical pharmacists, and Intellium for clinical education and navigating payer policies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millennium Health company profile →
Zevacor
HQ: United States
Website
- Description: Provider of PET and SPECT radiopharmaceuticals, developing, manufacturing, and distributing compounds for PET and SPECT imaging to aid in the diagnosis, monitoring, and management of medical conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zevacor company profile →
Eurobio Scientific
HQ: France
Website
- Description: Provider of fully integrated in vitro diagnostic solutions and life-science research products, from discovery to commercialization. Offerings include transplantation diagnostics (HLA typing, AlloMap heart transplant monitoring), infectious disease diagnostics (pathogen ID, tetanus immune status, COVID-19), immunology and oncology diagnostics, plus cell culture media and molecular biology reagents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurobio Scientific company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DIAsource Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DIAsource Diagnostics
2.2 - Growth funds investing in similar companies to DIAsource Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DIAsource Diagnostics
4.2 - Public trading comparable groups for DIAsource Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →